导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 45.82% | 434/3406 |
| 近一周 | -1.49% | 2592/4640 |
| 近一月 | 0.93% | 561/4620 |
| 近一季 | 2.66% | 901/4413 |
| 近半年 | 51.04% | 358/3979 |
| 近一年 | 40.01% | 474/3341 |
| 近两年 | 68.05% | 338/2453 |
| 近三年 | 31.55% | 640/1946 |
| 成立以来 | 213.90% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
-1.64% 2722/3635 |
3.19% 1117/4076 |
47.49% 457/4523 |
- - |
| 2024 | 12.77% 1213/3464 |
-4.42% 1663/2808 |
-6.29% 1906/3014 |
27.53% 218/3130 |
-1.28% 1644/3464 |
| 2023 | -18.30% 1798/2655 |
1.93% 1481/2280 |
-6.86% 1727/2385 |
-9.07% 1773/2515 |
-5.36% 1332/2655 |
| 2022 | -27.98% 1519/2208 |
-19.09% 1430/1919 |
5.65% 850/2016 |
-17.65% 1627/2113 |
2.30% 986/2208 |
| 2021 | 11.50% 401/1822 |
-6.58% 1022/1255 |
24.88% 103/1330 |
-6.35% 918/1466 |
2.05% 711/1822 |
| 2020 | 60.09% 122/1246 |
3.01% 127/1028 |
28.82% 91/1067 |
5.48% 916/1164 |
14.37% 281/1184 |
| 2019 | 40.36% 254/1092 |
32.06% 183/754 |
-9.76% 686/804 |
7.29% 95/850 |
9.79% 193/918 |
| 2018 | -26.10% 370/834 |
- - |
- - |
- - |
-10.67% 214/691 |
| 2017 | -10.82% 537/714 |
- - |
- - |
- - |
- - |
| 2016 | -24.29% 470/605 |
- - |
- - |
- - |
- - |
| 2015 | 51.62% 17/575 |
- - |
- - |
- - |
- - |
| 2014 | 10.98% 206/237 |
- - |
- - |
- - |
- - |
| 2013 | 71.42% 3/186 |
- - |
- - |
- - |
- - |
| 2012 | -1.21% 127/140 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 创金合信全球医药生物股票发起(QDII)C | 1.8048 | 37.74% |
| 泰信现代服务业混合 | 2.0450 | 32.88% |
| 易方达标普生物科技人民币A | 1.7298 | 28.02% |
| 永赢高端装备智选混合发起A | 1.1625 | 27.65% |
| 永赢高端装备智选混合发起C | 1.1467 | 27.52% |
| 金信稳健策略混合A | 2.2741 | 23.08% |
| 金信精选成长混合A | 1.6584 | 22.49% |
| 金信精选成长混合C | 1.6361 | 22.31% |
| 东方人工智能主题混合C | 1.5534 | 22.12% |
| 金信行业优选混合发起式A | 2.7474 | 21.61% |
| 易方达创业板ETF联接A VS. () |